Advanced search
Showing result 1 - 5 of 13 essays matching the above criteria.
-
1. Non-coding RNAs as therapeutic agents : The future of therapy
University essay from Uppsala universitet/Institutionen för biologisk grundutbildningAbstract : Non-coding RNA (ncRNA) therapeutics are based on short oligonucleotides, both naturally occurring and artificial, which target RNA in a site-specific way to modulate gene expression. As of today, 12 synthetically produced ncRNA-based drugs are available on the market in the US and Europe, and there is a possibility of more to be approved in the near future. READ MORE
-
2. Killer acquisitions and European merger control in the digital era
University essay from Lunds universitet/Institutionen för handelsrättAbstract : The Big Tech companies, more precisely the five American giants: Google, Apple, Facebook, Amazon and Microsoft, have been performing a massive number of startup acquisitions and strengthening their dominant position in the market. In an economical study about mergers in the pharmaceutical sector the term killer acquisition was firstly adopted to define a transaction in which an incumbent, after acquiring a innovative target, terminates the development of the target’s innovations in order to prevent a future competitor. READ MORE
-
3. Determinants of Short-Term Value Creation through M&A for the Acquirer -The event study of the pharmaceutical industry focus on the Western European market
University essay from Lunds universitet/Företagsekonomiska institutionenAbstract : Purpose: The first objective is to find whether M&A create value for pharmaceutical acquiring companies in the Western European market from a short-term perspective. Then we aim to examine the determinants of value creation for the pharmaceutical acquirer in the Western European market. READ MORE
-
4. Do Mergers and Acquisitions Create Value for Acquirers? Short- and Long-Term Event Study on the Pharmaceutical Industry of Europe
University essay from Lunds universitet/Nationalekonomiska institutionenAbstract : In this thesis, the short- and long-term event study methodology are applied in order to assess whether M&As, in the pharmaceutical industry, create any abnormal return for the acquirer. The majority of the previous research finds a negative abnormal return but the short-term event study seems to generate slightly positive abnormal returns outside the U. READ MORE
-
5. End of a blockbuster? – Preventing evergreening of pharmaceutical patents under EU competition law
University essay from Lunds universitet/Juridiska institutionenAbstract : The pharmaceutical industry is dependent on the granting of patents. Patents make it possible for pharmaceutical companies to invest in the necessary R&D to bring new drugs to the market. This benefits consumers and the health care sector at large. READ MORE
